Insider Transactions in Q4 2025 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2025
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
4,000
-0.58%
|
-
|
|
Nov 26
2025
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
5,166
-6.15%
|
$191,142
$37.29 P/Share
|
|
Nov 25
2025
|
Sven Wehrwein Director |
SELL
Open market or private sale
|
Direct |
4,967
-12.63%
|
$188,746
$38.0 P/Share
|
|
Nov 25
2025
|
Sven Wehrwein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,967
+11.21%
|
$94,373
$19.95 P/Share
|
|
Nov 24
2025
|
Sven Wehrwein Director |
SELL
Open market or private sale
|
Direct |
5,033
-12.77%
|
$186,221
$37.32 P/Share
|
|
Nov 24
2025
|
Sven Wehrwein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,033
+11.33%
|
$95,627
$19.95 P/Share
|
|
Nov 21
2025
|
Maggie Yuen Director |
SELL
Open market or private sale
|
Direct |
3,000
-20.88%
|
$105,000
$35.72 P/Share
|
|
Nov 13
2025
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
6,000
-0.86%
|
-
|